Decision guidelines for prophylactic replacement of Björk-Shiley convexo-concave heart valves: impact on clinical

M J van Gorp1, E W Steyerberg, Y Van der Graaf

  • 1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.

Circulation
|April 14, 2004
PubMed

Insights

Prophylactic replacement of Björk-Shiley convexo-concave (BScc) valves largely followed guidelines in the Netherlands. Decision-analytic guidelines, updated and rigorously implemented, can guide clinical practice for complex cardiac valve decisions.

Area of Science:

  • Cardiology
  • Medical Decision Making
  • Public Health

Background:

  • Björk-Shiley convexo-concave (BScc) valves pose a risk of outlet strut fracture, necessitating consideration of prophylactic replacement.
  • Epidemiological and decision-analytic guidelines aim to inform BScc valve replacement strategies.

Purpose of the Study:

  • To assess the impact of epidemiological and decision-analytic guidelines on actual BScc valve replacement practices.
  • To evaluate the concordance between guideline recommendations and clinical decisions regarding BScc valve replacement.

Main Methods:

  • Retrospective cohort study of 2263 Dutch BScc patients with a mean follow-up of 11.3 years.
  • Analysis of outlet strut fracture, mortality, and BScc valve replacement rates.
  • Calculation of expected differences in life expectancy (LE) with and without valve replacement based on 1992 guidelines for surviving patients.

Main Results:

  • During 8 years of follow-up, 40% of patients died, and 11 experienced outlet strut fracture.
  • 10% of patients underwent BScc valve replacement, with increased rates after guideline introduction.
  • Patients with an estimated gain in LE were significantly more likely to undergo replacement (HR, 6.6).

Conclusions:

  • BScc heart valve replacement in the Netherlands generally aligned with established guidelines.
  • Individualized guidelines, supported by robust epidemiological data and rigorous implementation, can effectively shape clinical practice in complex scenarios.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...